TNFRSF1B and ovarian carcinoma: We have shown in a recently published paper that IL-6 in ovarian cancer ascites promotes the upregulation of TNFR2 on T cells, predominantly on Tregs, with the neutralisation of the bioactive IL-6 decreasing the proportion of TNFR2 [57].